Analyzing OSR (NASDAQ:OSRH) and Marblegate Acquisition (NASDAQ:GATE)

OSR (NASDAQ:OSRH) and Marblegate Acquisition (NASDAQ:GATE) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.

Insider and Institutional Ownership

55.3% of OSR shares are owned by institutional investors. Comparatively, 9.4% of Marblegate Acquisition shares are owned by institutional investors. 36.8% of OSR shares are owned by insiders. Comparatively, 71.2% of Marblegate Acquisition shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares OSR and Marblegate Acquisition”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OSR	$2.91 million	3.87	-$27.06 million	($0.33)	-0.97
Marblegate Acquisition	N/A	N/A	-$2.39 million	N/A	N/A

Marblegate Acquisition has lower revenue, but higher earnings than OSR.

Risk & Volatility

OSR has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500. Comparatively, Marblegate Acquisition has a beta of -0.5, indicating that its share price is 150% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for OSR and Marblegate Acquisition, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1	0	0	0	1.00
Marblegate Acquisition	0	0	0	0	0.00

Profitability

This table compares OSR and Marblegate Acquisition’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OSR	-363.26%	-7.24%	-5.41%
Marblegate Acquisition	N/A	N/A	N/A

Summary

Marblegate Acquisition beats OSR on 5 of the 9 factors compared between the two stocks.

About OSR

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.

About Marblegate Acquisition

Marblegate Acquisition Corp. does not have significant operations. The company focuses on effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies primarily in the education, business services, consumer products, and healthcare sectors. The company was incorporated in 2020 and is based in Rye, New York.